Which has the lower trailing P/E, ALNY or MTD?

MTD has the lower trailing P/E: ALNY trades at 39.05 and MTD at 33.34. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ALNY or MTD?

Over the past five years, ALNY grew revenue faster — ALNY at a 47.53% CAGR versus MTD at 3.54%.

Is ALNY or MTD more profitable?

MTD runs the higher net margin — ALNY at 16.82% versus MTD at 21.91%.

How have ALNY and MTD total returns compared?

Over the past 10 years, ALNY delivered 13.05% and MTD delivered 13.43% annualized total return. Past performance doesn't predict future results.

Alnylam Pharmaceuticals, Inc. (ALNY) vs Mettler-Toledo International Inc. (MTD)

A side-by-side comparison of Alnylam Pharmaceuticals, Inc. and Mettler-Toledo International Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 2, 2026. Differences are shown without an overall score or investment verdict.

ALNY

Alnylam Pharmaceuticals, Inc.

$30.93B

$231.18HealthcareDelayed quote: Oct 1, 2026, 4:00 PM EDT

MTD

Mettler-Toledo International Inc.

$29.93B

$1,481.17HealthcareDelayed quote: Oct 1, 2026, 4:00 PM EDT

Total return — ALNY vs MTD

growth of $100 · dividends reinvested · last 10y

ALNY +238.8% (+13.0%/yr)MTD +262.9% (+13.8%/yr)MTD compounded faster over this window

ALNY MTD

ALNY vs MTD: by the numbers

•ALNY is the larger company ($30.93B vs $29.93B market cap).
•MTD trades at the lower trailing earnings multiple (33.34 vs 39.05 P/E), one valuation lens rather than an overall verdict.
•MTD converts more revenue to profit (21.91% vs 16.82% net margin).
•ALNY grew revenue faster over the past five years (47.53% vs 3.54% CAGR).

Metrics side by side

Valuation

Metric	ALNY	MTD
P/E ratio	39.05	33.34
Forward P/E	34.67	31.30
P/S ratio	6.44	7.24
P/B ratio	22.84	2334.16
EV / EBITDA	28.93	24.51
FCF yield	1.75%	2.89%

Profitability

Metric	ALNY	MTD
Gross margin	79.72%	58.35%
Operating margin	20.81%	28.41%
Net margin	16.82%	21.91%
ROE	59.67%	7062.40%
ROIC	24.71%	38.19%

Growth (annualized)

Metric	ALNY	MTD
Revenue CAGR (5Y)	47.53%	3.54%
EPS CAGR (5Y)	N/A	10.81%
FCF CAGR (5Y)	N/A	2.13%
Total return CAGR (5Y)	3.71%	1.28%

Frequently asked

Which has the lower trailing P/E, ALNY or MTD?: MTD has the lower trailing P/E: ALNY trades at 39.05 and MTD at 33.34. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ALNY or MTD?: Over the past five years, ALNY grew revenue faster — ALNY at a 47.53% CAGR versus MTD at 3.54%.
Is ALNY or MTD more profitable?: MTD runs the higher net margin — ALNY at 16.82% versus MTD at 21.91%.
How have ALNY and MTD total returns compared?: Over the past 10 years, ALNY delivered 13.05% and MTD delivered 13.43% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ALNY analysis Full MTD analysis Interactive comparison tool

Dig into the metrics

Alnylam Pharmaceuticals P/E ratio Mettler-Toledo International P/E ratio Alnylam Pharmaceuticals ROE Mettler-Toledo International ROE Alnylam Pharmaceuticals operating margin Mettler-Toledo International operating margin Alnylam Pharmaceuticals revenue growth Mettler-Toledo International revenue growth Alnylam Pharmaceuticals free cash flow Mettler-Toledo International free cash flow

Alnylam Pharmaceuticals & Mettler-Toledo International appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 2, 2026.